Статьи и публикации

Случай диагностики болезни Андерсона-Фабри
Случай болезни Фабри у взрослого глазами кардиолога и генетика
Поражение сердца при болезни Фабри: как заподозрить, диагностировать и лечить?

Schiffmann R, Ries M, Timmons M, Flaherty JT, Brady RO. Long-term therapy with agalsidase alfa for Fabry disease: safety and effects on renal function in a home infusion setting. Nephrol Dial Transplant 2006;21:345-54

Schiffmann R, Scott LJ. Pathophysiology and assessment of neuropathic pain in Fabry disease. Acta Paediatr Suppl 2002; 91:48-52

Schindler D, Bishop DF, Wolfe DE, Wang AM, Egge H, Lemieux RU et al. Neuroaxonal dystrophy due to lysosomal а-N-acetylgalactosaminidase deficiency. N Engl J Med 1989;320:1735-40

Schleicher E, Kolm V, Ceol M, Nerlich A. Structural and functional changes in diabetic glomerulopathy. Kidney Blood Press Res 1996;19:305-15

Schram AW, Hamers MN, Tager JM. The identity of а-galactosidase B from human liver. Biochim Biophys Acta 1977;482:138-44

Schweitzer EJ, Drachenberg CB, Bartlett ST. Living kidney donor and recipient evaluation in Fabry's disease. Transplantation 1992;54:924-7

Scriba K. Zur Pathogenese des Angiokeratoma Corporis Diffusum Fabry mit Cardio-Vasorenalem Symptomenkomplex. Verh Dtsch Ges Pathol 1950;34:221

Sessa A, Meroni M, Battini G, Maglio A, Nebuloni M, Tosoni A et al. Renal transplantation in patients with Fabry disease. Nephron 2002;91:348-51

Shabbeer J, Robinson M, Desnick RJ. Detection of а-galactosidase A mutations causing Fabry disease by denaturing high performance liquid chromatography. Hum Mutat 2005;25:299-305

Shelley ED, Shelley WB, Kurczynski TW. Painful fingers, heat intolerance, and telangiectases of the ear: easily ignored childhood signs of Fabry disease. Pediatr Dermatol 1995; 12:215-19

Sher NA, Letson RD, Desnick RJ. The ocular manifestations in Fabry's disease. Arch Ophthalmol 1979;97:671-6

Sheth KJ, Bernhard GC. The arthropathy of Fabry disease. Arthritis Rheum 1979;22:781-3

Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJ et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 2000;91:66-7

Smith P, Heath D, Rodgers B, Helliwell T. Pulmonary vasculature in Fabry's disease. Histopathology 1991; 19:567-9

Sodi A, Ioannidis A, Pitz S. Ophthalmological manifestations of Fabry disease. In: Mehta A, Beck M, Sunder-Plassmann G, editors. Fabry disease – perspectives from 5 years of FOS. Oxford: Oxford PharmaGenesis Ltd; 2006: p. 249-61

Spada M, Pagliardini S. Screening for Fabry disease in end-stage nephropathies. J Inherit Metab Dis 2002;25 (Suppl 1):113

Spence MW, Clarke JT, D'Entremont DM, Sapp GA, Smith ER, Goldbloom AL et al. Angiokeratoma corporis diffusum (Anderson-Fabry disease) in a single large family in Nova Scotia. J Med Genet 1978;15:428-34

Spinelli L, Pisani A, Sabbatini M, Petretta M, Andreucci MV, Procaccini D et al. Enzyme replacement therapy with agalsidase beta improves cardiac involvement in Fabry's disease. Clin Genet 2004;66:158-65

Sweeley CC, Klionsky B. Fabry's disease: classification as a sphingolipidosis and partial characterization of a novel glycolipid. J Biol Chem 1963;238:3148-50

Takenaka T, Hendrickson CS, Tworek DM, Tudor M, Schiffmann R, Brady RO et al. Enzymatic and functional correction along with long-term enzyme secretion from transduced bone marrow hematopoietic stem/progenitor and stromal cells derived from patients with Fabry disease. Exp Hematol 1999a;27:1149-59

Takenaka T, Murray GJ, Qin G, Quirk JM, Ohshima T, Qasba P et al. Long-term enzyme correction and lipid reduction in multiple organs of primary and secondary transplanted Fabry mice receiving transduced bone marrow cells. Proc Natl Acad Sci USA 2000;97:7515-20

Страницы:
←3456789
11
→
из 12